ColoCare Cohort for 3 Study Sites in United States and Germany

Heidelberg (HD), Germany:
ColoCare-Study: Transdisciplinary Research in Colorectal Cancer Prognosis

Contact: Cornelia (Neli) Ulrich, Ph.D.

Study Website: http://www.nct-heidelberg.de/en/nct/abteilungen/praeventive-onkologie/colocare.phpExternal Web Site Policy

  • Number of Enrolled Cancer Patients/Survivors: 103 (recruitment ongoing)
  • Years of Diagnoses of Enrolled Cancer Patients/Survivors: 2010-present

Moffitt, U.S.:
Colorectal Cancer Outcomes, Prognosis, and Epidemiology Cohort (The COPE) (A sister cohort to ColoCare)

Contact: Erin Siegel, Ph.D.

  • Number of Enrolled Cancer Patients/Survivors: 150 (recruitment ongoing, goal 250 by 2012)
  • Years of Diagnoses of Enrolled Cancer Patients/Survivors: 2009-present

FHCRC, (Seattle) U.S.:
ColoCare-Study: Transdisciplinary Research in Colorectal Cancer Prognosis

Contact: Cornelia (Neli) Ulrich, Ph.D.

Study Website: http://www.fhcrc.org/science/phs/cprp/projects/colocare.htmlExternal Web Site Policy

  • Number of Enrolled Cancer Patients/Survivors: 201 (recruitment ongoing)
  • Years of Diagnoses of Enrolled Cancer Patients/Survivors: 2007-present
Cancer Sites Represented: Colon & Rectum
Biological Specimens Collected: Blood/Blood Fraction
Buccal Cells (HD, Seattle)
Normal Tissues
Germline DNA
Formalin Fixed Tumor Tissue
Fresh Frozen Tumor Tissue
Urine (HD, Seattle)
Stool (HD)
Treatment Outcome Measures: Physician/Medical Record Reported
  • Symptom Assessment
  • Acute Medical Event
  • Late Medical Event
  • Cancer Recurrence
  • Death
  • Other
Patient-Reported
  • Symptom Assessment
  • Quality of Life (4 time points over 12 months)
  • Cancer Recurrence (HD; Seattle)
Co-morbidities at Study Entry: Diabetes
Heart Disease
Pulmonary Disease (HD; Seattle)
Other (metabolic syndrome)
Lifestyle Factors: Smoking
Alcohol Use
Diet (HD, Seattle)
Physical Activity
Body Mass Index
Weight Loss/Control
Supplement Use
Other (anthropometrics)
Treatment Data: Surgery
Radiation
Chemotherapy
Medication (HD, Seattle)
Other
Treatment Data Assessed By: Electronic Record
Chart Abstraction
Patient Reported Questionnaire (HD, Seattle)
Is the study open to collaboration? Yes

Return to Top